The Utah Jazz announced on Thursday that their recent trade addition, Jaren Jackson Jr., will have surgery on his left knee during the NBA All-Star break. The decision follows an MRI scan performed as part of Jackson’s post-trade physical, revealing a pigmented villonodular synovitis (PVNS) in the knee joint.
Details on the Knee Condition and Its Impact
PVNS is a non-cancerous tumor affecting the knee’s lining, which can hinder movement if left untreated due to the abnormal growth of joint tissue. Jackson Jr., who joined the Jazz from the Memphis Grizzlies last Tuesday, was limited to just three games this season, despite averaging an impressive 22.3 points per game in about 24 minutes of playtime. The Utah Jazz won two of those three contests.
Uncertainty Surrounds Recovery Timeline and Season Outlook
The team has not disclosed a recovery timetable, choosing to wait until after the surgery to provide further updates. However, NBA reporter Chris Haynes indicated that the 7-foot forward is expected to miss the rest of the season, increasing concerns about the Jazz’s roster depth and outlook moving forward.
BREAKING: Utah Jazz star Jaren Jackson Jr. is likely to miss the remainder of the season to undergo surgery on his left knee to ensure his longterm health after a localized PVNS growth was discovered post trade, league sources tell me. pic.twitter.com/pHeJT8NphE
— Chris Haynes (@ChrisBHaynes) February 12, 2026
